Salveen Richter
Stock Analyst at Goldman Sachs
(3.56)
# 751
Out of 5,182 analysts
214
Total ratings
44.44%
Success rate
7.53%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLAY Relay Therapeutics | Maintains: Buy | $13 → $22 | $13.61 | +61.65% | 4 | Apr 28, 2026 | |
| QURE uniQure | Maintains: Neutral | $9 → $10 | $18.01 | -44.48% | 11 | Apr 20, 2026 | |
| AGIO Agios Pharmaceuticals | Maintains: Neutral | $28 → $32 | $24.89 | +28.57% | 11 | Apr 1, 2026 | |
| DNLI Denali Therapeutics | Maintains: Buy | $35 → $40 | $19.98 | +100.20% | 6 | Mar 26, 2026 | |
| RARE Ultragenyx Pharmaceutical | Downgrades: Neutral | $61 → $25 | $24.86 | +0.56% | 4 | Mar 24, 2026 | |
| GENB Generate Biomedicines | Initiates: Buy | $26 | $12.50 | +108.00% | 1 | Mar 24, 2026 | |
| MRNA Moderna | Maintains: Neutral | $36 → $41 | $47.33 | -13.37% | 11 | Feb 17, 2026 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $9 → $11 | $14.49 | -24.09% | 3 | Nov 5, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $14 → $16 | $24.45 | -34.56% | 4 | Oct 30, 2025 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $45 → $65 | $71.91 | -9.61% | 5 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $26 → $18 | $40.95 | -56.04% | 9 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $23.29 | +11.64% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $504 → $566 | $306.02 | +84.96% | 6 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $38 | $9.43 | +302.97% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $19 | $21.17 | -10.25% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $15 → $17 | $22.60 | -24.78% | 9 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $43.76 | -15.45% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $47 | $51.20 | -8.20% | 4 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $124 → $104 | $53.54 | +94.25% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $41 | $21.82 | +87.90% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $13.94 | -28.26% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $746.42 | +7.71% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $183.33 | +7.46% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $129.45 | -25.84% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $13.65 | -12.09% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $82 → $72 | $188.00 | -61.70% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $93.60 | -25.21% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $342.55 | +2.17% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $429.55 | +30.14% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $39.50 | -87.34% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $2.24 | +1,287.02% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $235.72 | -4.55% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $3.70 | +495.40% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $21.39 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $7.08 | +323.73% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $3.46 | +160.12% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $6.48 | -53.70% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $3.38 | +77.78% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $86.52 | -50.30% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $3.96 | -49.49% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $4.91 | +1,936.66% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $5.76 | +10,316.67% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $120.06 | -58.35% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $71.40 | -36.97% | 1 | Mar 17, 2020 |
Relay Therapeutics
Apr 28, 2026
Maintains: Buy
Price Target: $13 → $22
Current: $13.61
Upside: +61.65%
uniQure
Apr 20, 2026
Maintains: Neutral
Price Target: $9 → $10
Current: $18.01
Upside: -44.48%
Agios Pharmaceuticals
Apr 1, 2026
Maintains: Neutral
Price Target: $28 → $32
Current: $24.89
Upside: +28.57%
Denali Therapeutics
Mar 26, 2026
Maintains: Buy
Price Target: $35 → $40
Current: $19.98
Upside: +100.20%
Ultragenyx Pharmaceutical
Mar 24, 2026
Downgrades: Neutral
Price Target: $61 → $25
Current: $24.86
Upside: +0.56%
Generate Biomedicines
Mar 24, 2026
Initiates: Buy
Price Target: $26
Current: $12.50
Upside: +108.00%
Moderna
Feb 17, 2026
Maintains: Neutral
Price Target: $36 → $41
Current: $47.33
Upside: -13.37%
Amicus Therapeutics
Nov 5, 2025
Maintains: Neutral
Price Target: $9 → $11
Current: $14.49
Upside: -24.09%
Arcus Biosciences
Oct 30, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $24.45
Upside: -34.56%
Ionis Pharmaceuticals
Sep 26, 2025
Upgrades: Neutral
Price Target: $45 → $65
Current: $71.91
Upside: -9.61%
Sep 26, 2025
Downgrades: Sell
Price Target: $26 → $18
Current: $40.95
Upside: -56.04%
Sep 22, 2025
Initiates: Buy
Price Target: $26
Current: $23.29
Upside: +11.64%
Sep 16, 2025
Maintains: Buy
Price Target: $504 → $566
Current: $306.02
Upside: +84.96%
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $9.43
Upside: +302.97%
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $21.17
Upside: -10.25%
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $22.60
Upside: -24.78%
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $43.76
Upside: -15.45%
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $51.20
Upside: -8.20%
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $53.54
Upside: +94.25%
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $21.82
Upside: +87.90%
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $13.94
Upside: -28.26%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $746.42
Upside: +7.71%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $183.33
Upside: +7.46%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $129.45
Upside: -25.84%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $13.65
Upside: -12.09%
Jan 13, 2025
Maintains: Neutral
Price Target: $82 → $72
Current: $188.00
Upside: -61.70%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $93.60
Upside: -25.21%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $342.55
Upside: +2.17%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $429.55
Upside: +30.14%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $39.50
Upside: -87.34%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $2.24
Upside: +1,287.02%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $235.72
Upside: -4.55%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $3.70
Upside: +495.40%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $21.39
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $7.08
Upside: +323.73%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $3.46
Upside: +160.12%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $6.48
Upside: -53.70%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $3.38
Upside: +77.78%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $86.52
Upside: -50.30%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $3.96
Upside: -49.49%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $4.91
Upside: +1,936.66%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $5.76
Upside: +10,316.67%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $120.06
Upside: -58.35%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $71.40
Upside: -36.97%